Home › Funds › BRAIDWELL LP › EWTX
BRAIDWELL LP position in EWTX
EDGEWISE THERAPEUTICS INC · Health Care
BRAIDWELL LP reported holding 1,996,965 shares of EWTX (EDGEWISE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$81.1M, representing 3.19% of its reported portfolio and ranking #4 among its reported holdings. BRAIDWELL LP has disclosed EWTX holdings in 8 of the last 8 reported quarters, going back to Q3 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How BRAIDWELL LP's EWTX position evolved
BRAIDWELL LP first disclosed a stake in EWTX in Q3 2024 at 1,958,310 shares (US$52.3M). The position peaked in Q4 2025 at 5,210,831 shares, worth US$129.3M. Across 8 filings, BRAIDWELL LP increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 1,996,965 shares valued at US$81.1M — a reduction of -350,618 shares quarter over quarter.. Notable position changes include a 112% increase in Q2 2025 (shares rose 24% over the following quarter), a 55% trim in Q1 2026 (shares rose 29% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 1.96M | $52.27M | New |
| Q4 2024 | 2.33M | $62.27M | Add |
| Q1 2025 | 2.46M | $54.09M | Add |
| Q2 2025 | 5.21M | $68.31M | Add |
| Q3 2025 | 5.21M | $84.52M | Hold |
| Q4 2025 | 5.21M | $129.31M | Hold |
| Q1 2026 | 2.35M | $73.95M | Reduce |
| Q2 2026 | 2.00M | $81.14M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About EWTX and 13F data
EWTX (EDGEWISE THERAPEUTICS INC) is a Health Care company. 47 other funds we track also report a position in EWTX — the largest reported positions include ORBIMED ADVISORS LLC (US$630.5M), Paradigm Biocapital Advisors LP (US$415.1M), RA CAPITAL MANAGEMENT, L.P. (US$341.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding EWTX
- ORBIMED ADVISORS LLC 15.52M sh · $630.52M · Q2 2026
- Paradigm Biocapital Advisors LP 10.22M sh · $415.05M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 8.39M sh · $341.00M · Q2 2026
- Novo Holdings A/S 5.35M sh · $217.37M · Q2 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 4.73M sh · $192.12M · Q2 2026
- PERCEPTIVE ADVISORS LLC 4.37M sh · $177.71M · Q2 2026
- BAKER BROS. ADVISORS LP 3.70M sh · $150.40M · Q2 2026
- Siren, L.L.C. 3.18M sh · $129.39M · Q2 2026
- Cormorant Asset Management, LP 2.51M sh · $101.98M · Q2 2026
- Integral Health Asset Management, LLC 2.00M sh · $81.26M · Q2 2026
- MPM BioImpact LLC 1.62M sh · $65.85M · Q2 2026
- First Light Asset Management, LLC 1.10M sh · $44.50M · Q2 2026
FAQ
How long has BRAIDWELL LP held EWTX?
BRAIDWELL LP has disclosed EWTX holdings in 8 of the last 8 reported quarters, going back to Q3 2024.
What is BRAIDWELL LP's current position in EWTX?
As of Q2 2026, BRAIDWELL LP holds 2.00M shares of EWTX (EDGEWISE THERAPEUTICS INC), valued at $81.14M, representing 3.19% of its reported portfolio and ranking #4.
Has BRAIDWELL LP been buying or selling EWTX?
In the latest 13F filing (Q2 2026), BRAIDWELL LP reduced its position in EWTX. The position peaked in Q4 2025 at 5.21M shares.
Which other funds hold EWTX?
Other major institutional holders of EWTX include ORBIMED ADVISORS LLC, Paradigm Biocapital Advisors LP, RA CAPITAL MANAGEMENT, L.P., among 47 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.